ReviewChildren (Basel, Switzerland)2024
Perspectives and Challenges of Telemedicine and Artificial Intelligence in Pediatric Dermatology.
Review in Children (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07705386 (Development of an AI-Assisted Diagnostic Tool for Mycosis Fungoides and Other Cutaneous Lymphoproliferative Diseases Using Microscopic Image Analysis), which is not on this map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development of an AI-Assisted Diagnostic Tool for Mycosis Fungoides and Other Cutaneous Lymphoproliferative Diseases Using Microscopic Image Analysis: A Training and Validation Study
Who cites it
7 citing papers in PubMed.
- Toward Child-Centred Artificial Intelligence in Pediatric Emergency Medicine: A Perspective on Clinical Decision Support, Stakeholder Engagement and Education.Pediatric reports · 2026Article
- Diagnostic accuracy of artificial intelligence versus 263 pediatric clinicians for childhood exanthems.European journal of pediatrics · 2026Article
- Skin of Color in Pediatric Dermatology: A Cross-Sectional Retrospective Analysis Addressing Inclusive Diagnosis and Care.Life (Basel, Switzerland) · 2026Article
- Integration of a tele-dermatology model for Epidermolysis Bullosa improves patient outreach: a before and after observational study.Frontiers in digital health · 2026Article
- MTAKD: multi-teacher agreement knowledge distillation for edge AI skin disease diagnosis.Scientific reports · 2025Article
- Climate Change and Pediatric Skin Health: Emerging Threats, Innovations, and Equity Gaps.Cureus · 2025Review
- Telemedicine adoption in Ecuador: an assessment of physician perceptions and knowledge towards its benefits and limitations.mHealth · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric dermatology represents one of the most underserved subspecialties in pediatrics. Artificial intelligence (AI) and telemedicine have become considerable in dermatology, reaching diagnostic accuracy comparable to or exceeding that of in-person visits. This work aims to review the current state of telemedicine and AI in pediatric dermatology, suggesting potential ways to address existing issues and challenges.
methodsWe conducted a literature review including only articles published in the last 15 years. A total of 458 studies were identified, of which only 76 were included.
resultsMost of the studies on telemedicine evaluate accuracy focused on concordance, which ranges from 70% to 89% for the most common pediatric skin diseases. Telemedicine showed the potential to manage chronic dermatological conditions in children, as well as decrease waiting times, and represents the chance for unprivileged populations to overcome barriers limiting access to medical care. The main limitations of telemedicine consist of the language barrier and the need for adequate technologies and acceptable image-quality video, which can be overcome by AI. AI-driven apps and platforms can facilitate remote consultations between pediatric dermatologists and patients or their caregivers. However, the integration of AI into clinical practice faces some challenges ranging from technical to ethical and regulatory. It is crucial to ensure that the development, deployment, and utilization of AI systems conform to the seven fundamental requirements for trustworthy AI.
conclusionThis study supplies a detailed discussion of open challenges with a particular focus on equity and ethical considerations and defining possible concrete directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.